CureCancer - mycancer.gr is an innovative, digital, patient-centric tool! Quality of Life 10. 02. 2021 CureCancer - mycancer.gr was admitted, after an evaluation, to the digital portal "Elevate Greece"! Elevate Greece is an important action of the Ministry of Development and Investment - General Secretariat for Research and Technology. It is the official digital portal for start-ups in Greece. CureCancer - mycancer.gr is an innovative, digital, patient-centric tool operated by the patient himself. CureCancer - mycancer.gr's mission is the supportive care of the cancer patient. Digital health has made a highly positive difference in the treatment and care of cancer. It is especially useful in times of pandemic, such as that of Covid-19 which we are now experiencing. The CureCancer - mycancer.gr digital tool helps the patient to communicate with his doctor "for a better quality of life"! We are grateful and honored for the selection and promotion of CureCancer - mycancer.gr by the Digital Portal of the Ministry and we look forward to productive collaborations! Tags: cancer , telemedicine , CureCancer - mycancer.gr
Webinar: Cancer prevention and treatment, make it with your lifestyle! Events, Seminars, & Publications 01. 05. 2024 Register now, attend the Webinar and see the lifestyle tips!Find out what times are appropriate to sunbathe, what a cancer vaccine offers us and how to quit smoking!We invite you to attend the Webinar...[Read more]
Webinar: Cancer and how to protect our patients Events, Seminars, & Publications 17. 07. 2024 Cancer is one of the most serious health problems seen today. The education of health care professionals and their contribution to the multidisciplinary approach of cancer is an urgent need. Education...[Read more]
Health Innovation Ecosystems Events, Seminars, & Publications 25. 03. 2024 We sincerely thank the Hellenic Digital Health Cluster-HDHC for the invitation to present the contribution of mycancer at the event, entitled «Health Innovation Ecosystems» addressing the challenges o...[Read more]